Skip to main content
logo
Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.225
-0.015 (-1.21%)
Sep 28, 2026, 1:26 PM EDT - Market open

Cardiff Oncology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.510.590.680.490.390.36
Revenue Growth
-6.79%-13.18%39.96%26.42%7.52%-1.91%
Gross Profit
-34.82-34.74-36.17-32.37-26.72-17.02
Operating Income
-42.27-48.96-48.65-45.41-39.9-28.86
Net Income
-40.08-45.88-45.46-41.47-38.73-28.32
Earnings Per Share
-0.59-0.69-0.95-0.93-0.89-0.73
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
34.5258.391.7574.82105.27140.82
Total Debt
0.460.831.522.152.723.12
Net Cash (Debt)
34.0657.4790.2272.67102.55137.7
Net Cash Growth
-51.18%-36.30%24.15%-29.13%-25.53%5.83%
Net Cash Per Share
0.500.861.891.632.353.53

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-40.85-37.92-37.69-30.89-33.82-23.04
Capital Expenditures
-0.06-0.04-0.08-0.58-1.01-0.21
Free Cash Flow
-40.92-37.97-37.77-31.47-34.83-23.25
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-8320.08%-8256.32%-7123.13%-9305.74%-10337.31%-8037.60%
Pretax Margin
-7884.06%-7732.04%-6651.68%-8492.01%-10026.94%-7880.50%
Profit Margin
-7888.98%-7736.26%-6655.20%-8496.93%-10033.16%-7887.19%
FCF Margin
-8054.33%-6402.53%-5530.45%-6448.57%-9022.28%-6474.93%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
189.89319.20422.72135.50162.04702.51